Role of von Willebrand factor in tumour cell-induced platelet aggregation: differential regulation by NO and prostacyclin
about
Identification, regulation and role of tissue inhibitor of metalloproteinases-4 (TIMP-4) in human plateletsInteraction between circulating cancer cells and platelets: clinical implicationNanoparticle-induced platelet aggregation and vascular thrombosisElucidation of flow-mediated tumour cell-induced platelet aggregation using an ultrasound standing wave trap.Overexpression of tumstatin in genetically modified megakaryocytes changes the proangiogenic effect of platelets.Platelets and cancer: a casual or causal relationship: revisited.Integrins and bone metastasis: integrating tumor cell and stromal cell interactions.Platelet--cancer interactions: mechanisms and pharmacology of tumour cell-induced platelet aggregation.Identification of a novel platelet antagonist that binds to CLEC-2 and suppresses podoplanin-induced platelet aggregation and cancer metastasisPlatelets in tumor progression: a host factor that offers multiple potential targets in the treatment of cancer.Amorphous silica nanoparticles aggregate human platelets: potential implications for vascular homeostasis.Antiplatelet agents for cancer treatment: a real perspective or just an echo from the past?APT102, a novel adpase, cooperates with aspirin to disrupt bone metastasis in mice.Membrane type-1 matrix metalloproteinase stimulates tumour cell-induced platelet aggregation: role of receptor glycoproteins.Platelet count as a predictor of metastasis and venous thromboembolism in patients with cancer.Differential eNOS-signalling by platelet subpopulations regulates adhesion and aggregation.
P2860
Q24672897-FFCFC9B3-87B7-474B-8333-10D0DD097157Q26778920-C512FAE3-555D-4271-BECD-9A8FA473F597Q28191813-B2607CAF-8FB0-4093-BEAC-63FAC56B56C9Q30468939-B129F2EC-9037-4807-ACE2-BF2B1DFF28A2Q33414123-65648012-2247-44E7-A9DA-342BB6EC4472Q34294719-01309D5C-EB33-47F6-9E1B-20611998D018Q34441622-097E8502-27A0-43A2-B69B-9DBF003EC1D5Q35048404-2F71AF17-EC82-4EA7-AD44-5F6678221C8FQ36618989-4D5C51E4-EB62-45BE-ABA9-B11283B047EDQ38174455-1EAC230B-1EF8-4E46-B499-2D443B76008BQ41065390-8D9EB697-99A8-4D8C-93AD-63475525E377Q41420993-BB8983AD-18CD-4145-B2FD-3D89A27CCA6BQ41877140-0146CE47-D5AA-40E5-8B98-93FCEB8212FBQ41912198-2D6CBA51-DA23-40D8-A199-FF84C4EF86E8Q47400340-098EBA09-5977-4DA1-970B-238CA87E0510Q47671119-61942AC2-E2C3-44C7-93A3-1B1746DFB972
P2860
Role of von Willebrand factor in tumour cell-induced platelet aggregation: differential regulation by NO and prostacyclin
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Role of von Willebrand factor ...... ulation by NO and prostacyclin
@ast
Role of von Willebrand factor ...... ulation by NO and prostacyclin
@en
Role of von Willebrand factor ...... ulation by NO and prostacyclin
@nl
type
label
Role of von Willebrand factor ...... ulation by NO and prostacyclin
@ast
Role of von Willebrand factor ...... ulation by NO and prostacyclin
@en
Role of von Willebrand factor ...... ulation by NO and prostacyclin
@nl
prefLabel
Role of von Willebrand factor ...... ulation by NO and prostacyclin
@ast
Role of von Willebrand factor ...... ulation by NO and prostacyclin
@en
Role of von Willebrand factor ...... ulation by NO and prostacyclin
@nl
P2093
P2860
P356
P1476
Role of von Willebrand factor ...... ulation by NO and prostacyclin
@en
P2093
P2860
P304
P356
10.1038/SJ.BJP.0704343
P407
P577
2001-11-01T00:00:00Z